MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202611086922 A) filed by Mr. Akash Vikal; Md Afzal Rain; Mr. Samarendra Singh; Md Farhan Raza; Sofinur Ahmed; Dr. Rohit Bangwal; Mr. Issac V Cherain; and Sheikh Mohammad Faisal on July 16, 2026, for Stimuli-Responsive Targeted Hybrid Nanovesicular Drug Delivery System For Selective Cancer Therapy.
Inventors include Mr. Akash Vikal; Md Afzal Rain; Mr. Samarendra Singh; Md Farhan Raza; Sofinur Ahmed; Dr. Rohit Bangwal; Mr. Issac V Cherain; and Sheikh Mohammad Faisal.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: The present invention relates to multifunctional targeted nanovesicular drug delive...